In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1853 News Items found
Selwyn M. Vickers, M.D., FACS
Selwyn M. Vickers Named to amNY Metro and PoliticsNY’s Power Players in Healthcare List

The list acknowledges and celebrates healthcare leaders who envision a better future for all New Yorkers and constitute New York’s ever-expanding and constantly improving healthcare system.
MSK medical oncologist and genitourinary cancer specialist Emily Feld
Feature
Interpreting Bladder Cancer Symptoms in Men vs. Women: What You Should Know

Learn what bladder cancer symptoms can mean in men and women.
Nancy Schroeder and her husband Mark
In the Clinic
New Checkpoint Inhibitor Immunotherapy Treatment for Advanced Melanoma Shows Promise

Results from a phase 2 clinical trial report a combination of two checkpoint inhibitor immunotherapy drugs given before melanoma surgery prevents this aggressive skin cancer from coming back. This new drug combination also has fewer side effects than other immunotherapy treatments.
MSK hematologic oncologist Saad Usmani, who specializes in treating multiple myeloma.
FDA Approves Teclistamab, a Promising New Drug for Multiple Myeloma Targeting BCMA and CD3 Proteins

Learn how FDA approval of a new multiple myeloma drug will brighten the outlook for people with resistant forms of the disease.
Medical oncologist Ghassan Abou-Alfa led the clinical trial that resulted in the FDA’s approval of a new combination therapy for hepatocellular cancer.
FDA Approves New Immunotherapy Combination To Treat Advanced Liver Cancer

Patients with inoperable advanced liver cancer have a new option for treatment to extend their lives.
Memorial Sloan Kettering breast cancer patient Linda Dow
When Breast Cancer Surgery Isn’t an Option, Cryoablation Can Offer Hope

Learn about cryoablation for breast cancer at Memorial Sloan Kettering Cancer Center.
A slide being reviewed under a microscope
MSK Research Highlights, October 13, 2022

New research from Memorial Sloan Kettering Cancer Center (MSK) and the Sloan Kettering Institute suggests a therapeutic strategy to overcome resistance to PRMT5 inhibition in lymphoma; finds safety and clinical benefit using an engineered adenovirus in combination with immunotherapy against PD-1-resistant melanoma; and uncovers a new type of immune cell that plays a key role in establishing a healthy gut microbiome.
Two women and two young men at a high school graduation
Bladder Removal With Good Quality of Life: Results From New MSK Study

Learn how bladder removal to treat bladder cancer can be effective without impairing quality of life.
Perry Ortiz surrounded by his wife, daughter, and two sons
Celebrating Hispanic and Latino Heritage Month: Perry Ortiz

Perry Ortiz doesn’t remember having a seizure in 2016. Or being rushed to an operating room, where doctors confirmed Perry — a security supervisor at M...
Christianah Alli and Dr. Yasmin Khakoo
MSK Programs Offer Mentorship to Aspiring Physician-Scientists from the Bronx

The summer programs connect high school and medical school students with MSK faculty while offering the opportunity for student-to-student mentorship.